Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Pain is a common and disabling symptom in multiple sclerosis (MS). Current understanding of pain is that it is a complex phenomenon involving cognitive, emotional and behavioural dimensions. A biopsychosocial framework is therefore best used to manage pain, particularly in the context of a chronic disease such as MS that has a significant impact on health-related quality of life. This article describes the epidemiology of MS pain and its common types, particularly neuropathic pain, as well as the evidence for MS pain management strategies. It also outlines a pragmatic approach to the pharmacological management of neuropathic pain and highlights the role of specialist pain services in the management of MS pain.

More information Original publication

DOI

10.12968/bjnn.2012.8.5.267

Type

Journal article

Publisher

Mark Allen Group

Publication Date

2012-10-01T00:00:00+00:00

Volume

8

Pages

267 - 274

Total pages

7